Clinical trials of neoadjuvant immune checkpoint inhibitors for early-stage operable colon and rectal cancer

被引：0
|
作者：
Torhild Veen
Arezo Kanani
Dordi Lea
Kjetil Søreide
机构：
[1] Stavanger University Hospital,Department of Gastrointestinal Surgery
[2] Stavanger University Hospital,Gastrointestinal Translational Research Unit, Laboratory for Molecular Medicine
[3] Stavanger University Hospital,Department of Pathology
[4] University of Bergen,Department of Clinical Medicine
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Immunotherapy; Immune checkpoint inhibitor; Mismatch repair deficiency; Colon cancer; Rectal cancer; Study design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3135 / 3147
页数：12
相关论文
共 50 条
  • [31] Clinical Trials of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
    Dyhl-Polk, Anne
    Mikkelsen, Marta Kramer
    Ladekarl, Morten
    Nielsen, Dorte Lisbet
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [32] A retrospective cohort study of neoadjuvant chemoradiotherapy combined with immune checkpoint inhibitors in locally advanced rectal cancer
    Chen, Zhuo
    Zou, Zhuoling
    Qian, Min
    Xu, Qin
    Xue, Guojuan
    Yang, Juan
    Luo, Tinglan
    Hu, Lianjie
    Wang, Bin
    TRANSLATIONAL ONCOLOGY, 2024, 44
  • [33] Multidisciplinary Management of Early-Stage Rectal Cancer
    Phillips, John G.
    Hong, Theodore S.
    Ryan, David P.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (12): : 1577 - 1585
  • [34] Immune checkpoint inhibition in early-stage non-small cell lung cancer
    Cuppens, Kristof
    Du Pont, Bert
    Knegjens, Joost
    Maes, Brigitte
    Baas, Paul
    LUNG CANCER, 2024, 193
  • [35] Clinical Trials of Carbon Ion Radiotherapy for Early-Stage Breast Cancer
    Karasawa, K.
    Omatsu, T.
    Murata, K.
    Okonogi, N.
    Yamada, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E183 - E183
  • [36] Failure of bevacizumab in early-stage colon cancer
    Daniel J. Sargent
    Nature Reviews Clinical Oncology, 2011, 8 : 10 - 11
  • [37] Current status of immune checkpoint inhibition in early-stage NSCLC
    Vansteenkiste, J.
    Wauters, E.
    Reymen, B.
    Ackermann, C. J.
    Peters, S.
    De Ruysscher, D.
    ANNALS OF ONCOLOGY, 2019, 30 (08) : 1244 - 1253
  • [38] Neoadjuvant immune checkpoint inhibitors in cancer, current state of the art
    Le Saux, Olivia
    Lounici, Yasmine
    Wajda, Pauline
    Barrin, Sarah
    Caux, Christophe
    Dubois, Bertrand
    Ray-Coquard, Isabelle
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 157
  • [39] Patient colon and rectal operative outcomes when treated with immune checkpoint inhibitors
    Calini, Giacomo
    Abd El Aziz, A. Mohamed
    Abdalla, Solafah
    Saeed, A. Hamedelneel
    Lovely, K. Jenna
    D'Angelo, Anne -Lise
    Behm, T. Kevin
    Colibaseanu, T. Dorin
    Mathis, L. Kellie
    Larson, W. David
    EJSO, 2021, 47 (09): : 2436 - 2440
  • [40] Effectiveness of Neoadjuvant Chemoradiotherapy for Early-Stage Esophageal Cancer
    Shapiro, Joel
    van Lanschot, J. Jan B.
    Hulshof, Maarten C. C. M.
    van der Gaast, Ate
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 288 - 289
12345